NeuBase Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$1.82M, a 76.1% increase year-over-year.
  • NeuBase Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$13.7M, a 59.4% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.8M, a 32.9% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$25.4M, a 46.2% decline from 2020.
  • NeuBase Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$17.4M, a 33.5% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$13.7M -$1.82M +$5.81M +76.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$19.5M -$3.45M +$5.04M +59.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 -$24.6M -$4.09M +$5.83M +58.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-09
Q4 2022 -$30.4M -$4.37M +$3.36M +43.5% Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q3 2022 -$33.8M -$7.63M -$473K -6.61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$33.3M -$8.49M +$171K +1.98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$33.5M -$9.92M -$4.4M -79.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$29.1M -$7.73M -$3.66M -90.1% Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q3 2021 -$25.4M -$7.16M -$2.46M -52.3% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-21
Q2 2021 -$23M -$8.66M -$4.86M -128% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$18.1M -$5.52M -$1.14M -26.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-11
Q4 2020 -$16.9M -$4.07M +$439K +9.75% Oct 1, 2020 Dec 31, 2020 10-Q 2022-08-11
Q3 2020 -$17.4M -$4.7M +$15.9M +77.2% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 -$33.3M -$3.8M -$1.77M -86.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$31.5M -$4.38M -$2.35M -116% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$29.1M -$4.51M -$3.02M -203% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$26.1M -$20.6M -$14.2M -224% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-23
Q2 2019 -$11.9M -$2.03M -$1.49M -273% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$10.4M -$2.03M +$155K +7.09% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$10.6M -$1.49M +$2.66M +64.1% Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-26
Q3 2018 -$13.2M -$6.36M -$1.11M -21.2% Jul 1, 2018 Sep 30, 2018 10-K 2019-01-03
Q2 2018 -$12.1M -$545K +$3.36M +86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$15.5M -$2.18M +$5.51M +71.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-08-14
Q4 2017 -$21M -$4.15M +$2.82M +40.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-08-14
Q3 2017 -$23.8M -$5.24M +$1.39M +21% Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 -$25.2M -$3.9M +$3.8M +49.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$29M -$7.69M -$2.41M -45.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$26.6M -$6.98M -$830K -13.5% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$25.8M -$6.64M -$2.73M -69.7% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-22
Q2 2016 -$23M -$7.7M -$4.35M -130% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$18.7M -$5.28M -$1.88M -55.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$16.8M -$6.15M -$1.6M -35.3% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$15.2M -$3.91M -$822K -26.6% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-22
Q2 2015 -$14.4M -$3.35M -$1.29M -63.1% Apr 1, 2015 Jun 30, 2015 10-K 2016-12-22
Q1 2015 -$13.1M -$3.4M -$1.43M -72.8% Jan 1, 2015 Mar 31, 2015 10-K 2016-12-22
Q4 2014 -$11.6M -$4.54M -$2.52M -125% Oct 1, 2014 Dec 31, 2014 10-K 2016-12-22
Q3 2014 -$9.13M -$3.09M -$1.28M -71.3% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-14
Q2 2014 -$7.85M -$2.05M -$714K -53.3% Apr 1, 2014 Jun 30, 2014 10-K 2015-12-14
Q1 2014 -$7.13M -$1.97M -$1.68M -573% Jan 1, 2014 Mar 31, 2014 10-K 2015-12-14
Q4 2013 -$5.46M -$2.02M +$196K +8.86% Oct 1, 2013 Dec 31, 2013 10-K 2015-12-14
Q3 2013 -$5.65M -$1.8M -$1.87M -2774% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-22
Q2 2013 -$3.78M -$1.34M -$878K -190% Apr 1, 2013 Jun 30, 2013 10-K 2014-12-22
Q1 2013 -$2.9M -$292K +$1.12M +79.3% Jan 1, 2013 Mar 31, 2013 10-K 2014-12-22
Q4 2012 -$4.02M -$2.22M -$2.57M -732% Oct 1, 2012 Dec 31, 2012 10-K 2014-12-22
Q3 2012 -$1.45M $67.4K +$1.43M Jul 1, 2012 Sep 30, 2012 10-K 2014-12-22
Q2 2012 -$2.88M -$461K +$2.68M +85.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$5.56M -$1.41M -$1.26M -800% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$4.3M $351K +$800K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$5.1M -$1.36M Jul 1, 2011 Sep 30, 2011 10-K 2013-12-27
Q2 2011 -$3.14M -$2.96M -1677% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 -$157K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 -$449K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-02-14
Q2 2010 -$177K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.